| ||
| Combination therapy with everolimus may improve metastatic breast cancer outcomes HemOncToday "Based on these promising results, this combination warrants further study in hormone receptor-positive/HER-2–negative metastatic breast cancer after ... See all stories on this topic » | ||
| CTCs predict poor outcome from blood stem cell transplantation therapy for ... EurekAlert (press release) SAN ANTONIO — Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT ... See all stories on this topic » | ||
| A hero of hope on cancer Detroit Free Press The Metastatic Breast Cancer Network grieves with and for the Edwards family and the nation over the death of Elizabeth Edwards. ... See all stories on this topic » | ||
| Immunogen-Roche Breast-Cancer Drug Has Positive Response In Early Trial Wall Street Journal The latest results tested T-DM1 in 21 patients with metastatic--or spreading--breast cancer in conjunction with pertuzumab, a developmental antibody thought ... See all stories on this topic » | ||
| Industry update: Agents slow disease progression, improve daily function in ... Cancer Network Results from a phase II study by the GINECO* group showed the proportion of metastatic breast cancer patients without tumor progression at six months was ... See all stories on this topic » | ||
| New risk factors for brain metastases in breast cancer patients identified Sify Progesterone receptor negativity and a diagnosis of inflammatory breast cancer may also be valuable additions to a predictive model." Siripurapu added. ... See all stories on this topic » | ||
| ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with ... Business Wire (press release) "The data that have been reported with T-DM1 for the first-line treatment of HER2+ metastatic breast cancer are highly encouraging, both with T-DM1 as a ... See all stories on this topic » | ||
| Zoledronic acid fails to improve disease-free survival in early breast cancer? HealthJockey.com The Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer (AZURE) trial was initiated on 3360 patients with stage II/III breast cancer from ... See all stories on this topic » | ||
| Syndax Pharmaceuticals' Entinostat in Combination Shows Activity in Breast Cancer PR Newswire (press release) "With chemotherapy as the primary treatment option for triple negative breast cancer patients, these results are encouraging that this patient population ... See all stories on this topic » | ||
| Roche's Avastin Fails to Beat Chemotherapy in Early Breast-Cancer Patients Bloomberg 24 they would review Avastin's use in metastatic breast tumors. A clinical trial that Roche says supports expanded use of the treatment was inconsistent ... See all stories on this topic » | ||
| Novartis Withdraws US and EU sNDAs for Zometa in Breast Cancer Genetic Engineering News Azure involved 3360 pre- and postmenopausal women with early breast cancer, and the interim data just reported showed that adding Zometa to standard ... See all stories on this topic » | ||
| Endobronchial Ultrasound WSOC Charlotte In patients with cancers in the chest area (like lung and breast cancer), the traditional method of lymph node biopsy is through a mediastinoscopy, ... See all stories on this topic » | ||
| NICE Says Patient Benefits Of Breast Cancer Drug Are Too Small To Justify Its ... Medical News Today (press release) Bevacizumab in combination with a taxane is not recommended for the first-line treatment of metastatic breast cancer. - Patients currently receiving ... See all stories on this topic » | ||
| SUO 2010 - Practical use of perioperative chemotherapy for invasive bladder ... UroToday Some argue that they don't give neoadjuvant chemo since the survival benefit is less than 10%, but for colon and breast cancer, it is only 7%, ... See all stories on this topic » | ||
| Roche puts its faith in pipeline and personalised approach Pharma Times ... (and a decision on whether to proceed is likely to announced in February, and questions about Avastin (bevacizumab) as a breast cancer treatment. ... See all stories on this topic » | ||
| ||
| Stocks To Watch On Friday: Apple, AIG, Goldman Sachs, National Semiconductor ... Daily Markets (Il Sole 24 Ore) SMI Novartis – Co. says has initiated Phase III clinical trial to further study the treatment of Metastatic breast cancer, says study shows ... See all stories on this topic » | ||
| Drugs are safe, active in patients normally ineligible for clinical trial EurekAlert (press release) Stable disease was noted in two patients - one with metastatic sarcoma and one with breast cancer. Benchmarks of survival and response that would require ... See all stories on this topic » | ||
| AVEO's Tivozanib Study Shows Safety In Metastatic Breast Cancer Patients RTT News ... in 18 patients with metastatic breast cancer. These patients had prior taxane therapy and most of whom had prior bevacuzumab therapy. ... See all stories on this topic » | ||
| Geron Corporation Announces Closing of Its Public Offering of Common Stock Business Wire (press release) Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. The company is advancing anti-cancer ... See all stories on this topic » | ||
| Amgen's XGEVA Proves Effective In Treating Cancer Patients With Bone Metastases RTT News These new results were presented at the 33rd Annual San Antonio Breast Cancer Symposium. XGEVA was approved on November 18, 2010, by the US Food and Drug ... See all stories on this topic » | ||
| Alternative Treatments Aid In Breast Cancer Survival CBS42 ... is only approved when accompanying a standard endocrine therapy called tamoxifen, or when used as a second-line treatment for metastatic breast cancer. ... See all stories on this topic » |
| ||
| How Do Treatments For Metastatic Breast Cancer Work? | HEALTH MED By health The deal with of dispersion outdated commencing the creative locate is called metastasis, with the period is referred headed for as metastatic breast cancer. Sometimes, every one cancer cells perform not fail equal behind treatment ... HEALTH MED - http://www.healthmed.biz/ | ||
| Poor breast cancer prognosis associated with presence of ... By bjs San Antonio - Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with high-dose chemotherapy and blood stem cell transplant have shorter survival periods, according to a new ... Science Blog - http://scienceblog.com/ | ||
| Phase 2 Clinical Data on NKTR-102 in Metastatic Breast Cancer to ... Awada et. al., "Significant Efficacy in a Phase 2 Study of NKTR-102, a Novel Polymer Conjugate of Irinotecan, in Patients with Pre-Treated Metastatic Breast Cancer (MBC)". Poster Session 6: Treatment - Advanced Disease: Advanced ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html | ||
| CTCs Predict Poor Outcome From Blood Stem Cell Transplantation ... By AACR Communication Staff SAN ANTONIO — Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to ... AACR News - http://aacrnews.wordpress.com/ | ||
| FDA approves new dose of FASLODEX in the fight against metastatic ... By Anna "For women with metastatic breast cancer, the treatment approach centers on slowing the progression of cancer," said Gershon Locker, MD, Senior Medical Director AstraZeneca Medical Affairs. "FASLODEX 250 mg has been an option for some ... Anna D. Banks, MAS, GCDF - http://www.annabanks.com/ | ||
| Factors predictive of response to hormone therapy in breast cancer ... By Dr. Weiss METHODS: A computerized literature search through Medline and ASCO abstract databases was performed, applying the words "endocrine therapy" and "predictive markers" and each of the following: early and metastatic breast cancer, ... Arasys Perfector - iPico Ion Magnum - http://arasysperfector.com/articles/ | ||
| Poor breast cancer prognosis associated with presence of ... By admin Poor breast cancer prognosis associated with presence of circulating tumor, cancer stem cells - Bio -San Antonio - Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with ... Biology and Medicine - http://enterprisepost.com/biomed/ | ||
| Breast Cancer Mortality Rate 2008 – Health care for all ... By admin Metastatic cancer or Stage 4 is diagnosed when cells from the original breast tumor have spread to other parts of your body. It is estimated that nearly 155000 women in the U.S. are currently living with metastatic breast cancer This ... healthinfoblog.co.cc - http://healthinfoblog.co.cc/ | ||
| Everolimus plus tamoxifen delays disease progression in HR+/HER2 ... By admin Findings from a randomized, Phase II study of 111 patients showed the proportion of metastatic breast cancer patients without tumor progression at six months was 61.1% for those taking everolimus plus tamoxifen (95% confidence interval ... BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that a Phase 3 pivotal study with OncoVEXGM-CSF for the first line treatment of patients with ... Latest Health & Drugs News - http://news.drugs-expert.com/ | ||
| Study shows Novartis drug Afinitor® plus hormonal therapy delays ... Study Details: Abstract #S1-6This randomized Phase II trial evaluated the efficacy and safety of everolimus in 111 patients with HR+/HER2- metastatic breast cancer with prior exposure to AI treatment (in adjuvant and/or metastatic ... Skin Care Products Sale - http://www.skincareproductssale.com/ | ||
| Novartis' Zometa fails to meet Ph III primary endpoint in early ... "Based on these results, additional studies will evaluate the combination of everolimus with hormonal therapies as a second-line treatment for patients with HR+/HER2- metastatic breast cancer," he noted. ... thepharmaletter.com - http://www.thepharmaletter.com/ | ||
| What Are Causes and Treatment of Leukemia Cancer? | GEEK! By admin There is minimal pain during this time but still medications are aimed at alleviating the symptoms and in conjunction with other treatment methods. By: Dave Mathewsl. Health> Cancerl Nov 20, 2010. Metastatic Breast Cancer ... GEEK! - http://www.turkgeek.net/ | ||
| Exemestane May Help Fight Early Stage Breast Cancer « News and Views By Robert Glen Fogarty Exemestane is currently approved by the FDA when used following tamoxifen, a standard endocrine therapy, or as a second-line therapy for metastatic breast cancer. "The three available aromatase inhibitors are due to come off patent and ... News and Views - http://www.lockergnome.com/news/ | ||
| Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign ... By admin cancer cell, you could eventually use them to guide therapy for an individual. [ And] you could monitor it over time especially to assess response to treatment and modify treatment [if necessary]. Cancer cells mutate and can develop abnormalities that can be ... A study from scientists at the M.D. Anderson Cancer Center at the. University of Texas found that metastatic breast cancer patients who had both chemotherapy and transplants of their own stem cells and had CTCs in ... Yu's Blog - http://yu.toptreadmillreview.com/ |
| ||
| Understanding Inflammatory breast cancer - Types of Cancer - Zimbio Inflammatory breast cancer and metastatic breast cancer are different kinds of ... inflamatory breast cancer The treatment of Inflammatory breast cancer ... www.zimbio.com/.../Understanding+Inflammatory+breast+can... | ||
| Halaven Approved for the Treatment of Late-Stage - Alexian ... The US Food and Drug Administration (FDA) has granted approval to Halaven™ ( eribulin mesylate) for the treatment of metastatic breast cancer patients who ... alexian-cancer.org/.../halaven-approved-for-the-treatment-of-l... | ||
| Gamma Knife surgery for metastatic brain tumors from primary ... Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype. ... www.ncbi.nlm.nih.gov/pubmed/21121788 | ||
| New chemo drug specifically for metastatic breast cancer? My mom was diagnosed for the 6th time last week. After both breasts (almost 10 years apart), lungs, bones, and liver they found it in her colon. www.understanding-breast-cancer-treatment.com/.../new-chem... | ||
| CBCN - Canadian Breast Cancer Network Applauds Nova Scotia for ... Women with HER2 positive breast cancer now have access to TYKERB, ... ditosylate ) for the treatment of advanced or metastatic breast cancer in women whose ... www.cbcn.ca/index.php?pageaction=content.page&id... | ||
| Breast Cancer Topic: Afinitor - Latest studies ... study will form the basis for the next stage of the research which is using this treatment as second-line in certain metastatic breast cancer patients. ... community.breastcancer.org/forum/8/topic/761793 | ||
| Metformin Suppresses Metastasis Of Triple Negative Breast Cancer ... In fact, distant metastases in breast cancer patients resistant to treatment are thought to be largely composed of CD24-positive cells (CD24 expression ... foodforbreastcancer.com/.../metformin-suppresses-metastasis-o... | ||
| Syndax Pharmaceuticals' Entinostat in Combination Shows Activity ... Triple negative breast cancer (TNBC) is a sub-group of breast cancer that is ... in combination with erlotinib in metastatic lung cancer and as a single agent ... HDACs are therefore recognized as promising targets for cancer treatment. ... www.breitbart.com/article.php?id=xprnw.20101210...1 | ||
| Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences ... Treatment of the Physician's Choice (TPC) in Heavily Pretreated Patients with Locally Recurrent or Metastatic Breast Cancer in North America, Western Europe ... www.sacbee.com/2010/.../cancer-patients-may-reduce-fast.htm... | ||
| Abstract - Cancer Research ... metastasis, and resistance to endocrine therapy in human breast cancer ... while exogenous SDF1 treatment negated the inhibitory effects of treatment ... cancerres.aacrjournals.org/.../0008-5472.CAN-10-3185.abstra... | ||
| Table 2 : Molecular mechanisms of metastasis in breast cancer ... (SWOG-S0500), To test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated CTC levels at ... www.nature.com/nrclinonc/.../nrclinonc.2010.171_T2.html | ||
| Breast cancer meet to unveil advances - San Antonio Express-News The drug has U.S. Food and Drug Administration (FDA) approval for treatment in patients with metastatic breast cancer, but the FDA's own Oncologic Drugs ... www.mysanantonio.com/.../Breast-cancer-meet-to-unveil-adva... | ||
| High CTC levels predicted poor outcome in metastatic breast cancer CTCs add an independent prognostic marker in metastatic breast cancer at ... to be at high risk due to CTC may benefit from additional treatment options, ... oneclick.indiatimes.com/article/05TN39ZaNrceC?q=Paris | ||
| => Novartis International AG: Study shows Novartis drug Afinitor ... Novartis International AG: Study shows Novartis drug Afinitor® plus hormonal therapy delays disease progression in advan NOVARTIS. www.finanznachrichten.de/.../18792953-novartis-international... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment